Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal

Biochemical and Biophysical Research Communications

Volumn 439, Issue 1, 2013, Pages 96-102

  Michifuri, Yoshitaka ^a   Hirohashi, Yoshihiko ^a   Torigoe, Toshihiko ^a   Miyazaki, Akihiro ^a   Fujino, Jyunki ^a   Tamura, Yasuaki ^a   Tsukahara, Tomohide ^a   Kanaseki, Takayuki ^a   Kobayashi, Junichi ^a   Sasaki, Takanori ^a   Takahashi, Akari ^a   Nakamori, Kenji ^a   Yamaguchi, Akira ^a   Hiratsuka, Hiroyoshi ^a   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ALDEFLUOR assay; Cancer stem cell; Oral cancer; RASSF4; SPRR1B

Indexed keywords

ALDEHYDE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PROLINE RICH PROTEIN; PROLINE RICH PROTEIN 1B; UNCLASSIFIED DRUG;

ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CELL GROWTH; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MOUTH SQUAMOUS CELL CARCINOMA; ONCOGENE RAS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ALDEFLUOR ASSAY; CANCER STEM CELL; CANCER STEM-LIKE CELL; CANCER-INITIATING CELL; CIC; CSC; NOD/SCID; NON-OBESE DIABETIC/SEVERE COMBINED IMMUNODEFICIENCY; ORAL CANCER; ORAL SQUAMOUS CELL CARCINOMA; OSCC; RAS ASSOCIATION DOMAIN FAMILY MEMBER 4; RASSF4; SMALL PROLINE-RICH PROTEIN-1B; SPRR1B;

ALDEHYDE DEHYDROGENASE; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; COLLAGEN; CORNIFIED ENVELOPE PROLINE-RICH PROTEINS; DRUG COMBINATIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LAMININ; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED NOD; MICE, SCID; MOUTH NEOPLASMS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOGLYCANS; RNA, SMALL INTERFERING; STEM CELLS; TUMOR SUPPRESSOR PROTEINS;

EID: 84883745834     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.08.021     Document Type: Article

References (32)

1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009, 45:309-316.
2. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., Visvader J., Weissman I.L., Wahl G.M. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006, 66:9339-9344.
3. Jordan C.T., Guzman M.L., Noble M. Cancer stem cells. N. Engl. J. Med. 2006, 355:1253-1261.
4. Park C.Y., Tseng D., Weissman I.L. Cancer stem cell-directed therapies: recent data from the laboratory and clinic. Mol. Ther. 2009, 17:219-230.
5. Hirohashi Y., Torigoe T., Inoda S., Takahashi A., Morita R., Nishizawa S., Tamura Y., Suzuki H., Toyota M., Sato N. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells. Immunotherapy 2010, 2:201-211.
6. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., Weissman I.L., Clarke M.F., Ailles L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 2007, 104:973-978.
7. Kanki K., Torigoe T., Hirai I., Sahara H., Kamiguchi K., Tamura Y., Yagihashi A., Sato N. Molecular cloning of rat NK target structure - the possibility of CD44 involvement in NK cell-mediated lysis. Microbiol. Immunol. 2000, 44:1051-1061.
8. Okamoto A., Chikamatsu K., Sakakura K., Hatsushika K., Takahashi G., Masuyama K. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol. 2009, 45:633-639.
9. Yoshida A. Molecular genetics of human aldehyde dehydrogenase. Pharmacogenetics 1992, 2:139-147.
10. Armstrong L., Stojkovic M., Dimmick I., Ahmad S., Stojkovic P., Hole N., Lako M. Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells 2004, 22:1142-1151.
11. Hess D.A., Meyerrose T.E., Wirthlin L., Craft T.P., Herrbrich P.E., Creer M.H., Nolta J.A. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 2004, 104:1648-1655.
12. Matsui W., Huff C.A., Wang Q., Malehorn M.T., Barber J., Tanhehco Y., Smith B.D., Civin C.I., Jones R.J. Characterization of clonogenic multiple myeloma cells. Blood 2004, 103:2332-2336.
13. Hess D.A., Wirthlin L., Craft T.P., Herrbrich P.E., Hohm S.A., Lahey R., Eades W.C., Creer M.H., Nolta J.A. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 2006, 107:2162-2169.
14. Pearce D.J., Taussig D., Simpson C., Allen K., Rohatiner A.Z., Lister T.A., Bonnet D. Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells 2005, 23:752-760.
15. Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., Jacquemier J., Viens P., Kleer C.G., Liu S., Schott A., Hayes D., Birnbaum D., Wicha M.S., Dontu G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567.
16. Chen Y.C., Chen Y.W., Hsu H.S., Tseng L.M., Huang P.I., Lu K.H., Chen D.T., Tai L.K., Yung M.C., Chang S.C., Ku H.H., Chiou S.H., Lo W.L. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem. Biophys. Res. Commun. 2009, 385:307-313.
17. Nishida S., Hirohashi Y., Torigoe T., Kitamura H., Takahashi A., Masumori N., Tsukamoto T., Sato N. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay. J. Urol. 2012, 188:294-299.
18. Kuroda T., Hirohashi Y., Torigoe T., Yasuda K., Takahashi A., Asanuma H., Morita R., Mariya T., Asano T., Mizuuchi M., Saito T., Sato N. ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and aldh1 high expression is associated with poor prognosis. PLoS One 2013, 8:e65158.
19. Inoda S., Hirohashi Y., Torigoe T., Nakatsugawa M., Kiriyama K., Nakazawa E., Harada K., Takasu H., Tamura Y., Kamiguchi K., Asanuma H., Tsuruma T., Terui T., Ishitani K., Ohmura T., Wang Q., Greene M.I., Hasegawa T., Hirata K., Sato N. Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma. J. Immunother. 2009, 32:474-485.
20. Morita S., Kojima T., Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000, 7:1063-1066.
21. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., Scholer H., Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998, 95:379-391.
22. Niwa H. Molecular mechanism to maintain stem cell renewal of ES cells. Cell Struct. Funct. 2001, 26:137-148.
23. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113:643-655.
24. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113:631-642.
25. Cabral A., Sayin A., de Winter S., Fischer D.F., Pavel S., Backendorf C. SPRR4, a novel cornified envelope precursor: UV-dependent epidermal expression and selective incorporation into fragile envelopes. J. Cell Sci. 2001, 114:3837-3843.
26. Tesfaigzi J., Carlson D.M. Expression, regulation, and function of the SPR family of proteins. A review. Cell Biochem. Biophys. 1999, 30:243-265.
27. Cabral A., Voskamp P., Cleton-Jansen A.M., South A., Nizetic D., Backendorf C. Structural organization and regulation of the small proline-rich family of cornified envelope precursors suggest a role in adaptive barrier function. J. Biol. Chem. 2001, 276:19231-19237.
28. De Heller-Milev M., Huber M., Panizzon R., Hohl D. Expression of small proline rich proteins in neoplastic and inflammatory skin diseases. Br. J. Dermatol. 2000, 143:733-740.
29. Cho D.H., Jo Y.K., Roh S.A., Na Y.S., Kim T.W., Jang S.J., Kim Y.S., Kim J.C. Upregulation of SPRR3 promotes colorectal tumorigenesis. Mol. Med. 2010, 16:271-277.
30. Tesfaigzi Y., Wright P.S., Belinsky S.A. SPRR1B overexpression enhances entry of cells into the G0 phase of the cell cycle. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285:L889-898.
31. Eckfeld K., Hesson L., Vos M.D., Bieche I., Latif F., Clark G.J. RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family. Cancer Res. 2004, 64:8688-8693.
32. van der Weyden L., Adams D.J. The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim. Biophys. Acta 2007, 1776:58-85.